COPD Clinical Trials in Chicago, IL

22 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	2 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)	Phase 3	AstraZeneca	2 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)	Phase 3	Hoffmann-La Roche	2 mi
COPD Resources, Education, and Activity Designed for You Study	N/A	Rush University Medical Center	2 mi
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	N/A	Pulmonx Corporation	2 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	2 mi
Inhaler Trainer Efficacy Study	N/A	Koronis Biomedical Technologies	2 mi
The Reducing REVISITS Study: A Cluster RCT	N/A	University of Chicago	2 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	2 mi
STRIVE Post-Market Registry Study	—	Olympus Corporation of the Americas	2 mi
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention	N/A	Seattle Institute for Biomedical and Clinical Research	2 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3	N/A	Apreo Health, Inc.	2 mi
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease	N/A	University of Alabama at Birmingham	2 mi
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home	N/A	Temple University	2 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	2 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	2 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	12 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	14 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD	Phase 2	Verona Pharma plc	21 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	21 mi
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease	Phase 3	Hoffmann-La Roche	21 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)	Phase 2	Uniquity One (UNI)	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.